Transcatheter aortic valve implant (TAVI) is the new most exciting treatment for aortic stenosis (AS) in the past two decades, looking aortic valve replacement (AVR), which is one of the most effective, well-known and 50 years old surgical procedure.This new approach has less than 10 years since first in man implantation and less than 5 years in a real post-commercial setting.TAVI has rapidly become a valuable alternative to surgery and medical therapy in high-risk patients with a transfemoral (TF) or transapical (TA) approach(PARTNER Trial).